Plain-English translation of NCT07089550 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
PELICAN is a 9-year study that follows patients with advanced prostate cancer who are receiving treatment. Researchers want to understand whether a specialized PET scan โ a type of imaging that shows how cancer cells behave โ can predict whether your treatment will work well and how long you might stay free of cancer progression.
Right now, doctors use PET scans mainly to find cancer, but researchers don't yet fully understand whether detailed measurements from these scans can predict which patients will respond best to treatment and which ones might need different therapies. This study aims to fill that gap so doctors can personalize treatment plans more effectively.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will have PSMA PET scans taken before you start treatment and at scheduled intervals during your therapy โ the study will follow you for up to 9 years. Researchers will collect detailed measurements from your scans and compare them to how well your treatment is working and how your cancer progresses over time. You'll also allow your medical team to share imaging results and treatment outcomes with the research team.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
Italy